Clinical Trial Update: Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 trial evaluating dose monitoring of busulfan in conditioning regimens with combination chemotherapy for Hodgkin lymphoma or Non-Hodgkin lymphoma p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• BUSULFAN (Busulfan)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma | EARLY_Phase 1 | Status: COMPLETED